Keyphrases
Weight Gain
100%
Epilepsy Patients
100%
CYP2C19 Polymorphism
100%
Divalproex Sodium
100%
Epilepsy
28%
Epilepsy Treatment
28%
Family History of Obesity
28%
Restriction Fragment Length Polymorphism
14%
Endocrine Disorders
14%
Female Patients
14%
Chi-square Test
14%
Seizure
14%
Treatment Length
14%
CYP2C19
14%
Acid Type
14%
Treatment Type
14%
Antiepileptic Drugs
14%
Gender-based
14%
Valproic Acid
14%
Intermediate Metabolizers
14%
Poor Metabolizer
14%
Family Type
14%
Paroxysmal
14%
Epilepsy Type
14%
Unprovoked Seizure
14%
Extensive Metabolizer
14%
Medicine and Dentistry
Valproate Semisodium
100%
CYP2C19
100%
Family History
25%
Body Weight
25%
Epileptic Seizure
25%
Treatment of Epilepsy
25%
Cross Sectional Study
12%
Polymerase Chain Reaction
12%
Restriction Fragment Length Polymorphism
12%
Treatment Duration
12%
Sodium Valproate
12%
Anticonvulsant
12%
Endocrine Disease
12%
Pharmacology, Toxicology and Pharmaceutical Science
CYP2C19
100%
Valproate Semisodium
100%
Cross-Sectional Study
12%
Sodium Valproate
12%
Anticonvulsive Agent
12%
Endocrine Disease
12%
Neuroscience
Cytochrome P450 2C19
100%
Treatment of Epilepsy
25%
Polymerase Chain Reaction
12%
Anticonvulsant
12%
Valproic Acid
12%
Restriction Fragment Length Polymorphism
12%
Endocrine Disease
12%